Pallas Health vs YourEra: Price, meds, and care compared
Quick verdict: For a choice between brand-name pens or clinician-selected compounded GLP-1, Pallas Health is best; for the lowest advertised compounded semaglutide rates on a 6-month plan, YourEra is best. This Pallas Health vs YourEra comparison highlights pricing structure, medication options, care model and shipping so you can decide which fits your priorities.
See Pallas plans starting at $139
Pallas Health vs YourEra at a glance
| Criteria | Pallas Health | YourEra |
|---|---|---|
| Starting price | Compounded semaglutide $139 first month, then $199/mo avg | Semaglutide from $99/mo on 6 month plan; advertised as low as $79.20/mo on 6 month plan |
| Medication options | FDA-approved Wegovy, Ozempic, Zepbound and Mounjaro, plus compounded semaglutide and tirzepatide | Compounded semaglutide and tirzepatide only; no brand-name pens |
| Price structure | Compounded plans priced by medication not by milligram; intro first month pricing then 12 week renewal | Flat pricing at every dose on 6 month plan; lowest rates require a 6 month commitment |
| Provider care and hours | Clinician review and provider care included in plan price; care-team hours weekdays 9 AM to 5 PM ET | Provider consult, prescription, dose adjustments and 24/7 support included |
| Shipping | Free expedited shipping; compounded in the USA from licensed pharmacies | Free 1 to 2 day shipping from licensed US pharmacies; cold shipping included |
| Regulatory note | Compounded medications are not FDA approved | Compounded medications are not FDA approved |
1. Pricing and billing cadence
Pallas Health advertises compounded semaglutide with a first month from $139, then renewals billed as $597 every 12 weeks which is a $199/month average. Compounded tirzepatide is $179 first month then $897 every 12 weeks for a $299/month average. Brand-name options are cash pay with stated monthly rates for Wegovy, Ozempic, Zepbound and Mounjaro. YourEra presents lower entry pricing on a 6 month plan with semaglutide from $99/month and tirzepatide from $199/month, and an advertised as low as $79.20/month figure that reflects the 6 month plan. YourEra also notes that shorter plans cost more per month. The difference is clear: Pallas uses an introductory first month then a 12 week renewal schedule and offers brand-name choices; YourEra emphasizes a lower per month rate if you commit to six months.
2. Medication choices and how they are offered
Pallas Health supports both FDA-approved brand-name GLP-1s and clinician-personalized compounded semaglutide or tirzepatide prepared in the USA when a brand medication is not the right fit. YourEra dispenses compounded semaglutide and tirzepatide only and explicitly does not offer brand-name Ozempic, Wegovy, Mounjaro or Zepbound. If having the option of a brand-name pen matters, that is a distinctive advantage for Pallas Health. If you are comfortable with compounded-only options and want the lowest advertised compounded monthly rates on a 6 month plan, YourEra is positioned for that need.
3. Pricing behavior as doses change
Pallas prices its compounded plans by medication rather than by milligram, stating that titrating up does not raise the plan price. YourEra also advertises same price at every dose on the 6 month plan. Both providers present flat dose pricing, but Pallas calls out that its renewal cadence is every 12 weeks and that the intro month is a first month price. YourEra warns that the lowest advertised per month rates require a six month commitment and shorter plans cost more per month.
Compare Pallas medication options
4. Care model, support and shipping
Pallas Health is 100 percent online with a US licensed clinician reviewing your history and personalizing the plan; many states are asynchronous and 43 of 50 need no video visit, but a video visit is required in seven states plus Washington D.C. Provider care is included in the plan price and care-team hours are weekdays 9 AM to 5 PM ET. YourEra connects you with a licensed US clinician online and bundles the consult, prescription, cold shipping, dose adjustments and 24/7 support into one flat plan price. Both use licensed US compounding pharmacies and free discreet shipping, but YourEra highlights 1 to 2 day delivery and 24/7 support while Pallas highlights free expedited shipping and asynchronous intake in most states.
Regulatory and eligibility notes
Both vendors clearly state that compounded medications are not FDA approved finished drug products. Both say prescriptions are issued only if a licensed clinician determines treatment is appropriate after evaluation and eligibility is determined by a US licensed clinician. Pallas notes that it does not manufacture or compound medication; compounded medications are prepared by US licensed compounding pharmacies and the medication you receive may differ in appearance from any product shown on the site.
Final comparison and who should choose which
In short, Pallas Health is the direct pick if you want the option of FDA approved brand pens alongside clinician-personalized compounded preparations and a clinician that can choose the route. YourEra is the direct pick if your priority is the lowest advertised compounded semaglutide or tirzepatide monthly rate on a 6 month plan with bundled consult, cold shipping and 24/7 support.
Start with Pallas Health intake
Choose one if
- Choose Pallas Health if you want a clinician who can pick between FDA approved brand-name GLP-1s and a US compounded alternative, with an intro rate such as compounded semaglutide $139 first month then $199/month on average and no membership fee.
- Choose YourEra if you want lower advertised compounded semaglutide or tirzepatide pricing on a 6 month plan, flat price at every dose, bundled consult and 24/7 support and are comfortable committing to six months for the lowest rate.
Primary keyword: Pallas Health vs YourEra